Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhongke Health Industry Group is a leading Chinese enterprise specializing in the research, development, and production of high-tech health products and Traditional Chinese Medicine (TCM). Established in 1996 and headquartered in Nanjing, the company is renowned for its expertise in medicinal fungi, particularly Ganoderma lucidum (Reishi mushroom). Their flagship products, including Ganoderma spore oil and spore powder, are widely utilized as adjuvant therapies in oncology and for general immune system enhancement. The group operates multiple GMP-certified manufacturing facilities and maintains a strong focus on integrating modern biotechnology with traditional natural medicine. With a significant market presence in China and international exports, Zhongke Health continues to lead in the field of natural health supplements and chronic disease management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhongke Health Industry Group Jiangsu Pharmaceutical.